Graph Therapeutics Taps Parse GigaLab to Accelerate AI-First Immunology Drug Discovery
Parse Biosciences and Graph Therapeutics have entered into a strategic partnership to build one of the largest and most comprehensive immune cell perturbation atlases to date.
AI-First Immunology Drug Discovery | 22/01/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy